INTRODUCTION
D e p r e s c r i b i n g , Ba s t r u c t u r e d a p p r o a c h t o d r u g discontinuation^1 is rapidly becoming a trend worldwide. Though the Western world has accepted and adopted this approach towards prudent and rational therapy, the concept continues to be controversial in developing countries. The decision to deprescribe any medicine is complicated by the dearth of risk-benefit data and risk of therapeutic failure or withdrawal symptoms. But deprescribing has proven to be a legitimate solution to the age-old challenges of non-adherence, polypharmacy, risk of adverse drug reactions (ADRs), and use of potentially inappropriate medications (PIMs). As the responsibility of prescribing and monitoring of drug therapy falls primarily on physicians, understanding their views on deprescribing is of utmost importance. Hopefully the decision is made after weighing both the risks and benefits of deprescribing.
METHOD
This study is an observational, questionnaire-based survey of 422 registered medical practitioners within a radius of 10 km from Mathikere (Bangalore), with a minimum qualification of MBBS. Over 8 months, face-to-face interviews were conducted using a validated instrument 'Perceptions, Attitudes and Challenges of Physicians towards Deprescribing' (PACPD-12) ( Table 1) . 2 
RESULTS
The majority of Indian doctors (71.8%) agreed that deprescribing is beneficial. While 56.9% doctors chose to deprescribe in all groups of patients, benzodiazipines (34.6%), anti-depressants (33.2%), anti-psychotics (32.5%), and anticonvulsants (32.5%) were the most common candidate drugs for deprescribing. The prime reason for deprescribing (58.8%) was to reduce harm to patient, followed by latest guidelines where medication is not indicated (49.1%), reducing the cost of treatment (43.1%), and pill burden (32.2%). About 88.2% of doctors had a specific approach to deprescribing medications. The STOPP-START criterion was used by 44.8% of doctors, while 6.6% preferred Beers criteria for deprescribing. A majority of doctors (66.5%) believed deprescribing provides more benefit than harm to patients. With regard to methods that would help with depescribing, 57% felt that flags by pharmacists would be helpful; 49% believed that training on deprescribing of specific medications would also help. Among challenges, 55.2% of doctors felt that prescriptions provided by another doctor was a barrier. Concern about ADR (49.5%) and damaged relation with the original physician (41.7%) were other barriers noted. About 65.4% of doctors were confident in deprescribing. The existence of PIMs listed in Beers criteria (53.8%), acute symptoms possibly related to medication (51.7%), the large number of prescription medications (46%), and advanced age (39.8%) were the most opted factors that would make a doctor more likely to deprescribe.
DISCUSSION
Our finding that most doctors supported deprescribing was also found by Nadarajan et al. (2016) . 3 Our study indicated that deprescribing was preferred in all age groups, though most deprescribing studies focus on the elderly. The wellestablished risk of chronic benzodiazepine use, coupled with good data that they can be discontinued safely with strict monitoring, may be the reason for their being the most preferred drugs for deprescribing. 4 Similar to Nadarajan et al., we also found that the top three reasons for deprescribing were to reduce harm, followed by reducing pill burden for patients and medications with minimal benefits to patients. 3 About half of the physicians appreciated Beers and STOPP/START criteria as useful tools for deprescribing.
Recognizing barriers to deprescribing is helpful in finding ways to implement and overcome these obstacles. Uncertainty of the rationale behind prescription by another physician, possibly due to the rapid growth in the number of specialist and subspecialist departments that has resulted in fragmentation of patient care, was a major challenge. Minimal communication between doctors, inadequate transfer of information at care interfaces, lack of pharmacists on the clinical team, and difficulty accessing medical records also pose challenges to deprescribing among Indian physicians. 
